Gary Bourgeault
Long only, research analyst, portfolio strategy, media

Short Term And Long-Term Catalysts That Will Drive Mesa Laboratories Further Up

An unusual earnings report that revealed its usually predictable and profitable Biological Indicators division had underperformed, resulted in Mesa Laboratories (NASDAQ:MLAB) taking a big hit over a three-day period, dropping from $67.33 on August 6, 2013 to $58.79 on the close of trading on August 9, 2013.

As the anomaly was understood by investors, the share price started to rebound, already soaring almost 5% on Monday, August 12, 2013, to close at $61.63 per share. Having dropped just under 14%, there is still a lot of upside in the near term, and over the long term will continue on its upward run.

With the incident leading to the miss in the latest quarter having already been taken care...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
Money back guarantee. Seeking Alpha PRO members receive a no-questions-asked refund for membership on months paid and not used. Details